Analyst Ratings for Seattle Genetics (SGEN) [Neutrals]
SGEN Rating Summary
SGEN Price Target Summary
- Highest: $37.00 (Goldman Sachs)
- Lowest: $10.00 (Citadel Securities)
- Average: $20.14
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$20.14 (-42.4%)
Avg. $ Target:
$20.14 (-42.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
37.00 (N/A) |
36.33 | 34.95 | -3.8% | Details |
| 2/13/2013 | Needham & Company | Downgrade | Hold (Buy) |
N/A (N/A) |
29.24 | 34.95 | 19.53% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Neutral (N/A) |
24.00 (N/A) |
23.23 | 34.95 | 50.45% | Details |
| 9/7/2012 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
29.68 | 34.95 | 17.76% | Details |
| 11/2/2010 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
15.63 | 34.95 | 123.61% | Details |
